BWFA
ANIK icon

Baltimore-Washington Financial Advisors’s Anika Therapeutics ANIK Stock Holding History

Baltimore-Washington Financial Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,239
Closed -$207K – 71
2016
Q4 		$207K Sell
4,239
-30,087
-88% -$1.39M 0.06% 73
2016
Q3 		$1.64M Sell
34,326
-34,974
-50% -$1.73M 0.47% 61
2016
Q2 		$3.72M Buy
69,300
+515
+0.7% +$24.3K 1.11% 46
2016
Q1 		$3.08M Sell
68,785
-251
-0.4% -$10.2K 0.93% 47
2015
Q4 		$2.63M Buy
69,036
+7,905
+13% +$302K 0.82% 58
2015
Q3 		$1.95M Buy
61,131
+7,291
+14% +$254K 0.62% 68
2015
Q2 		$1.78M Buy
53,840
+9,950
+23% +$355K 0.53% 69
2015
Q1 		$1.81M Buy
43,890
+3,600
+9% +$146K 0.53% 69
2014
Q4 		$1.64M Buy
40,290
+14,535
+56% +$568K 0.49% 68
2014
Q3 		$944K Buy
25,755
+1,365
+6% +$59K 0.3% 74
2014
Q2 		$1.13M Buy
24,390
+1,525
+7% +$67.8K 0.35% 76
2014
Q1 		$940K Sell
22,865
-14,685
-39% -$546K 0.32% 74
2013
Q4 		$1.43M Buy
37,550
+2,180
+6% +$67.3K 0.48% 69
2013
Q3 		$845K Buy
35,370
+19,130
+118% +$429K 0.33% 72
2013
Q2 		$276K Buy
+16,240
New +$234K 0.12% 84

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Baltimore-Washington Financial Advisors's ANIK Position: Q1 2017 in Review

Baltimore-Washington Financial Advisors sold out of Anika Therapeutics (ANIK) in Q1 2017, closing a stake of 4,239 shares — an estimated $207K sold.

Baltimore-Washington Financial Advisors first reported a position in ANIK in Q2 2013 and held it in 15 quarters. The position peaked at $3.72M in Q2 2016. 156 funds tracked by Wall St. Rank hold ANIK as of Q1 2017.

  • Baltimore-Washington Financial Advisors reported no remaining Anika Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Baltimore-Washington Financial Advisors sold 4,239 Anika Therapeutics shares in Q1 2017, an estimated $207K.
  • Baltimore-Washington Financial Advisors first reported a position in Anika Therapeutics in Q2 2013 and held it in 15 quarters.
  • Baltimore-Washington Financial Advisors's Anika Therapeutics position peaked at $3.72M in Q2 2016.
  • 156 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2017.

Based on Baltimore-Washington Financial Advisors's 13F filing for Q1 2017, filed 18 Apr 2017.